Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response Guided Therapy with Pegasys in Chronic Hepatitis B
NCT01456312Phase 4Unknown
- Sponsor
- Gangnam Severance Hospital
- Start
- Sep 2012
- Primary completion
- Feb 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Gangnam Severance Hospital. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01456312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456312.